posted on 2023-12-27, 12:03authored byMd Anisuzzaman Chowdhury, Jessica M. Collins, David A. Gell, Sharn Perry, Michael C. Breadmore, Sarah Shigdar, Anna E. King
Aptamers
are functional oligonucleotide ligands used for the molecular
recognition of various targets. The natural characteristics of aptamers
make them an excellent alternative to antibodies in diagnostics, therapeutics,
and biosensing. DNA aptamers are mainly single-stranded oligonucleotides
(ssDNA) that possess a definite binding to targets. However, the application
of aptamers to the fields of brain health and neurodegenerative diseases
has been limited to date. Herein, a DNA aptamer against the brain-derived
neurotrophic factor (BDNF) protein was obtained by in vitro selection.
BDNF is a potential biomarker of brain health and neurodegenerative
diseases and has functions in the synaptic plasticity and survival
of neurons. We identified eight aptamers that have binding affinity
for BDNF from a 50-nucleotide library. Among these aptamers, NV_B12
showed the highest sensitivity and selectivity for detecting BDNF.
In an aptamer-linked immobilized sorbent assay (ALISA), the NV_B12
aptamer strongly bound to BDNF protein, in a dose-dependent manner.
The dissociation constant (Kd) for NV_B12
was 0.5 nM (95% CI: 0.4–0.6 nM). These findings suggest that
BDNF-specific aptamers could be used as an alternative to antibodies
in diagnostic and detection assays for BDNF.